Mikhael El-Chami
Clinical Cardiac Electrophysiology · Atlanta, GANPI 1386739571
Payments from drug & device makers
Across 411 payments — averaging $2654.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$860K
- Boston Scientific$191K
- Cvrx, Inc.$36K
- Abbott$2K
- Biotronik Inc.$2K
- Biosense Webster, Inc.$289
- plus $200 from 2 others
Across 3 payments — averaging $441.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1K
What the payments were for
- Consulting fees$36,93122%
- Speaking & faculty fees$104,65961%
- Travel & lodging$22,22813%
- Food & beverage$7,7535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 240 | $859,560 |
| Boston Scientific | 136 | $191,293 |
| Cvrx, Inc. | 8 | $35,877 |
| Abbott | 13 | $1,851 |
| Biotronik Inc. | 5 | $1,827 |
| Biosense Webster, Inc. | 7 | $289 |
| Cardiofocus, Inc. | 1 | $125 |
| EBR Systems, Inc. | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Micra$79,784
- Watchman$5,994
- GENERAL - THERAPIES$4,584
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$2,250
- CLINICAL TRIAL PRODUCT$1,875
- S-ICD System Magnet$1,250
- AVEIR$1,117
- Barostim Neo System$586
- AMPLATZER AMULET$180
- WATCHMAN FLX$170
- Farapulse$150
- Attain$148
- ENSITE PRECISION$138
- SQ RX PULSE GENERATOR$137
- HeartLight System$125
- Rivacor$118
- Solia$118
- Edora$118
- Acticor$118
- BioMonitor$118
How this compares
$1,090,897 in reported general payments places this provider in the 90th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 609 | $701,485 |
| XareltoRivaroxaban | 142 | $168,538 |
| EntrestoSacubitril/Valsartan | 17 | $26,675 |
| Flecainide Acetate | 360 | $14,454 |
| Metoprolol Succinate | 495 | $6,448 |
| Mexiletine Hcl | 29 | $4,276 |
| Amiodarone Hcl | 112 | $2,917 |
| SotalolSotalol Hcl | 141 | $2,716 |
| Dofetilide | 14 | $2,582 |
| Nebivolol Hcl | 18 | $2,552 |
| Valsartan | 52 | $1,701 |
| ClopidogrelClopidogrel Bisulfate | 136 | $1,550 |
| Rosuvastatin Calcium | 73 | $1,214 |
| Atorvastatin Calcium | 139 | $1,089 |
| Amlodipine Besylate | 160 | $993 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Atlanta
- David DelurgioAtlanta$4.2M
- Sandeep GoyalAtlanta$1.3M
- Sricharan KantipudiAtlanta$663K
- Anshul PatelAtlanta$615K
- Michael LloydAtlanta$444K
- Anand ShahAtlanta$380K
- Thomas DeeringAtlanta$237K
- Faisal MerchantAtlanta$215K
- Stacy WestermanAtlanta$149K
- Bruce StamblerAtlanta$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.